Ark Biosciences
Shanghai, CN · 1 known investors
Ark Biosciences (爱科百发) is a biopharmaceutical company developing innovative drugs for respiratory diseases and pediatric conditions, with a pipeline covering RSV, ADHD, idiopathic pulmonary fibrosis (IPF), and COPD. Its products include the RSV fusion inhibitor ziresovir (AK0529) and an approved ADHD treatment, aimed at patients in China and globally.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Ark Biosciences do?
- Ark Biosciences (爱科百发) is a biopharmaceutical company developing innovative drugs for respiratory diseases and pediatric conditions, with a pipeline covering RSV, ADHD, idiopathic pulmonary fibrosis (IPF), and COPD. Its products include the RSV fusion inhibitor ziresovir (AK0529) and an approved ADHD treatment, aimed at patients in China and globally.
- Who are Ark Biosciences's investors?
- Ark Biosciences's investors include Decheng Capital.
- Where is Ark Biosciences headquartered?
- Ark Biosciences is headquartered in Shanghai, CN.